The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized comparison of ibrutinib versus ofatumumab in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase III RESONATE trial.
John C. Byrd
Research Funding - Pharmacyclics
Jennifer R. Brown
Consultant or Advisory Role - GlaxoSmithKline; Pharmacyclics
Honoraria - Janssen
Susan Mary O'Brien
Research Funding - Pharmacyclics
Jacqueline Claudia Barrientos
Consultant or Advisory Role - Pharmacyclics
Honoraria - Janssen
Research Funding - Pharmacyclics
Neil E. Kay
Research Funding - Pharmacyclics
Nishitha M. Reddy
Consultant or Advisory Role - Pharmacyclics
Honoraria - Janssen
Research Funding - Pharmacyclics
Steven E. Coutre
Consultant or Advisory Role - Pharmacyclics
Research Funding - Pharmacyclics
Constantine Tam
Consultant or Advisory Role - Pharmacyclics (U)
Expert Testimony - Pharmacyclics (U)
Stephen P. Mulligan
Consultant or Advisory Role - Janssen; Pharmacyclics
Honoraria - Janssen Australia
Ulrich Jäger
Honoraria - Janssen-Cilag
Steve Devereux
Consultant or Advisory Role - Pharmacyclics
Honoraria - Pharmacyclics
Paul M. Barr
Research Funding - Pharmacyclics
Richard R. Furman
Consultant or Advisory Role - Janssen; Pharmacyclics
Honoraria - Janssen
Thomas J. Kipps
Consultant or Advisory Role - AbbVie; Celgene; Genentech; Pharmacyclics
Florence Cymbalista
Honoraria - Janssen; Pharmacyclics
Maria Fardis
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Jesse S. McGreivy
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Fong Clow
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Danelle Frances James
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Peter Hillmen
Consultant or Advisory Role - Pharmacyclics (U)
Honoraria - Pharmacyclics